000 | 01824 a2200493 4500 | ||
---|---|---|---|
005 | 20250517210512.0 | ||
264 | 0 | _c20180924 | |
008 | 201809s 0 0 eng d | ||
022 | _a1532-8511 | ||
024 | 7 |
_a10.1016/j.jstrokecerebrovasdis.2018.02.054 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aUchiyama, Yuki | |
245 | 0 | 0 |
_aBotulinum Toxin Type A Treatment Combined with Intensive Rehabilitation for Gait Poststroke: A Preliminary Study. _h[electronic resource] |
260 |
_bJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association _cJul 2018 |
||
300 |
_a1975-1986 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGait _xdrug effects |
650 | 0 | 4 |
_aHemiplegia _xdrug therapy |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMuscle Spasticity _xdrug therapy |
650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
650 | 0 | 4 | _aPreliminary Data |
650 | 0 | 4 | _aRange of Motion, Articular |
650 | 0 | 4 |
_aStroke _xcomplications |
650 | 0 | 4 | _aStroke Rehabilitation |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKoyama, Tetsuo | |
700 | 1 | _aWada, Yosuke | |
700 | 1 | _aKatsutani, Masashi | |
700 | 1 | _aKodama, Norihiko | |
700 | 1 | _aDomen, Kazuhisa | |
773 | 0 |
_tJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association _gvol. 27 _gno. 7 _gp. 1975-1986 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jstrokecerebrovasdis.2018.02.054 _zAvailable from publisher's website |
999 |
_c28243082 _d28243082 |